eLife (Sep 2019)
Interferon lambda 4 impacts the genetic diversity of hepatitis C virus
- M Azim Ansari,
- Elihu Aranday-Cortes,
- Camilla LC Ip,
- Ana da Silva Filipe,
- Siu Hin Lau,
- Connor Bamford,
- David Bonsall,
- Amy Trebes,
- Paolo Piazza,
- Vattipally Sreenu,
- Vanessa M Cowton,
- STOP-HCV Consortium,
- Emma Hudson,
- Rory Bowden,
- Arvind H Patel,
- Graham R Foster,
- William L Irving,
- Kosh Agarwal,
- Emma C Thomson,
- Peter Simmonds,
- Paul Klenerman,
- Chris Holmes,
- Eleanor Barnes,
- Chris CA Spencer,
- John McLauchlan,
- Vincent Pedergnana
Affiliations
- M Azim Ansari
- Wellcome Centre Human Genetics, University of Oxford, Oxford, United Kingdom
- Elihu Aranday-Cortes
- ORCiD
- MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Glasgow, United Kingdom
- Camilla LC Ip
- Wellcome Centre Human Genetics, University of Oxford, Oxford, United Kingdom
- Ana da Silva Filipe
- MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Glasgow, United Kingdom
- Siu Hin Lau
- ORCiD
- MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Glasgow, United Kingdom
- Connor Bamford
- ORCiD
- MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Glasgow, United Kingdom
- David Bonsall
- Nuffield Department of Medicine and the Oxford NIHR BRC, University of Oxford, Oxford, United Kingdom
- Amy Trebes
- Wellcome Centre Human Genetics, University of Oxford, Oxford, United Kingdom
- Paolo Piazza
- Wellcome Centre Human Genetics, University of Oxford, Oxford, United Kingdom
- Vattipally Sreenu
- MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Glasgow, United Kingdom
- Vanessa M Cowton
- MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Glasgow, United Kingdom
- STOP-HCV Consortium
- Emma Hudson
- Nuffield Department of Medicine and the Oxford NIHR BRC, University of Oxford, Oxford, United Kingdom
- Rory Bowden
- ORCiD
- Wellcome Centre Human Genetics, University of Oxford, Oxford, United Kingdom
- Arvind H Patel
- MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Glasgow, United Kingdom
- Graham R Foster
- Blizard Institute, Queen Mary University, London, United Kingdom
- William L Irving
- ORCiD
- National Institute for Health Research (NIHR) Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and University of Nottingham, Nottingham, United Kingdom
- Kosh Agarwal
- Institute of Liver Studies, King's College Hospital, London, United Kingdom
- Emma C Thomson
- MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Glasgow, United Kingdom
- Peter Simmonds
- Nuffield Department of Medicine and the Oxford NIHR BRC, University of Oxford, Oxford, United Kingdom
- Paul Klenerman
- ORCiD
- Nuffield Department of Medicine and the Oxford NIHR BRC, University of Oxford, Oxford, United Kingdom
- Chris Holmes
- Department of Statistics, University of Oxford, Oxford, United Kingdom
- Eleanor Barnes
- Nuffield Department of Medicine and the Oxford NIHR BRC, University of Oxford, Oxford, United Kingdom
- Chris CA Spencer
- Wellcome Centre Human Genetics, University of Oxford, Oxford, United Kingdom
- John McLauchlan
- MRC-University of Glasgow Centre for Virus Research, Sir Michael Stoker Building, Glasgow, United Kingdom
- Vincent Pedergnana
- ORCiD
- Wellcome Centre Human Genetics, University of Oxford, Oxford, United Kingdom; Laboratoire MIVEGEC (UMR CNRS 5290, IRD, UM), Montpellier, France
- DOI
- https://doi.org/10.7554/eLife.42463
- Journal volume & issue
-
Vol. 8
Abstract
Hepatitis C virus (HCV) is a highly variable pathogen that frequently establishes chronic infection. This genetic variability is affected by the adaptive immune response but the contribution of other host factors is unclear. Here, we examined the role played by interferon lambda-4 (IFN-λ4) on HCV diversity; IFN-λ4 plays a crucial role in spontaneous clearance or establishment of chronicity following acute infection. We performed viral genome-wide association studies using human and viral data from 485 patients of white ancestry infected with HCV genotype 3a. We demonstrate that combinations of host genetic variants, which determine IFN-λ4 protein production and activity, influence amino acid variation across the viral polyprotein - not restricted to specific viral proteins or HLA restricted epitopes - and modulate viral load. We also observed an association with viral di-nucleotide proportions. These results support a direct role for IFN-λ4 in exerting selective pressure across the viral genome, possibly by a novel mechanism.
Keywords
- hepatitis C virus
- genome-to-genome analysis
- host-pathogen interactions
- interferon lambda 4
- innate immunity